Global Retirement Partners’s Myriad Genetics MYGN Stock Holding History

Global Retirement Partners’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.87K	Buy	+503	New	+$2.28K	﹤0.01%	3886
2023 Q4	–	Sell	-18	Closed	-$282	–	3433
2023 Q3	$282	Hold	18	–	–	﹤0.01%	3076
2023 Q2	$417	Hold	18	–	–	﹤0.01%	2987
2023 Q1	$394	Hold	18	–	–	﹤0.01%	2974
2022 Q4	$261	Hold	18	–	–	﹤0.01%	2911
2022 Q3	$0	Sell	18 -22	-55%	-$505	﹤0.01%	2876
2022 Q2	$1K	Buy	40 +3	+8%	+$62	﹤0.01%	2486
2022 Q1	$1K	Buy	+37	New	+$947	﹤0.01%	2453

Other funds holding MYGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Global Retirement Partners's MYGN Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Myriad Genetics (MYGN) in Q2 2026: 503 shares worth $2.87K. The stake represents ﹤0.01% of the portfolio and ranks #3886 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in MYGN as recently as Q3 2023.

Global Retirement Partners first reported a position in MYGN in Q1 2022 and has held it in 8 quarters since. 196 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

Global Retirement Partners held 503 shares of Myriad Genetics worth $2.87K as of Q2 2026.
Myriad Genetics was a new Global Retirement Partners position in Q2 2026.
Myriad Genetics made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #3886 holding.
Global Retirement Partners first reported a position in Myriad Genetics in Q1 2022 and has held it in 8 quarters since.
196 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.